FIELD: medicine.
SUBSTANCE: invention relates to medicine, in particular, to a formulation, a pharmaceutical composition, and a medicinal product having nootropic activity. Claimed composition contains N-carbamoylmethyl-4-phenyl-2-pyrrolidone and 4-phenylpyrrolidone-2.
EFFECT: implementation of the invention makes it possible to obtain a pharmaceutical composition and a drug having an increased stability as compared with the fonturacetam, an increased dissolution rate and a reduced hygroscopicity.
5 cl, 6 tbl, 11 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NOVEL COMPOSITIONS OF N-CARBAMOYLMETHYL-4-PHENYL-2-PYRROLIDONE | 2018 |
|
RU2699669C1 |
| NOVEL COMPOSITIONS OF N-CARBAMOYLMETHYL-4-PHENYL-2-PYRROLIDONE FOR TREATING AND PREVENTING OBESITY | 2019 |
|
RU2732245C1 |
| PHARMACEUTICAL COMPOSITION IN FORM OF SOLUTION FOR INJECTION AND METHOD FOR PRODUCTION THEREOF | 2013 |
|
RU2524651C1 |
| 4-PHENYL PYRROLIDINONE-2 DERIVATIVE, NOOTROPIC COMPOSITION THEREOF, METHOD FOR PRODUCING THEREOF AND METHOD PREVENTIVE TREATMENT OF NERVOUS SYSTEM DISORDERS | 2015 |
|
RU2611623C2 |
| TABLETTED PHARMACEUTICAL COMPOSITION AND METHOD FOR PRODUCING IT | 2013 |
|
RU2539375C1 |
| AGENT FOR NORMALIZATION OF ARTERIAL BLOOD PRESSURE AND METHOD OF TREATMENT OF HYPERTENSION | 2000 |
|
RU2183117C1 |
| PROCESS FOR THE PREPARATION OF 1-CARBAMOYLMETHYL-4-PHENYL-2-PYRROLIDONE | 2017 |
|
RU2663899C1 |
| AGENT FOR INCREASING LEVEL OF BRAIN NEUROTROPHIC FACTOR (BDNF) IN MODEL OF CHRONIC UNPREDICTABLE MODERATE STRESS | 2023 |
|
RU2836915C1 |
| METHOD OF PRODUCING FONTURACETAM FROM PHENIBUT | 2024 |
|
RU2827339C1 |
| PHARMACEUTICAL COMPOSITION ELICITING NOOTROPIC ACTIVITY AND METHOD FOR ITS PREPARING | 2003 |
|
RU2240783C1 |
